Professor Amanj Kurdi

Strathclyde Institute of Pharmacy and Biomedical Sciences

Contact

Personal statement

Professor Kurdi is a Professor of Pharmacoepidemiology and Pharmacy Practice. He specialises in Pharmacoepidemiology and Drug Utilisation Research, especially concerning cardiovascular diseases, diabetes, and antibiotics. This includes studying medication adherence and persistence through the analysis of secondary databases and patient-level data, utilising a range of statistical and analytical methods.

Additionally, Professor Kurdi is keen on exploring Health Service Research and the evaluation of health policies and clinical guidelines' effects. Open to both national and international collaborations with fellow researchers and academics, Dr. Kurdi actively participates in events and conferences like EuroDURG and ICPE, fostering a collaborative environment for advancing research in these areas.

Back to staff profile

Publications

Co-design and development of a community pharmacy-based CVD risk screening service in Saudi Arabia : a multi-stakeholders Nominal Group Technique (NGT) consensus method
Noorsaeed Solafa Mohamedwaly M, Almansour Hadi, Weir Natalie Mcfadyen, Kurdi Amanj
83rd FIP World Congress of Pharmacy and Pharmaceutical Sciences (2025)
Co-design and development of a community pharmacy-based CVD risk screening service in Saudi Arabia : a Multi-stakeholders Nominal Group Technique (NGT) Consensus method
Noorsaeed Solafa Mohamedwaly M, Almansour Hadi, Weir Natalie Mcfadyen, Kurdi Amanj
NORDIC Social Pharmacy Conference 2025 (2025)
Knowledge gaps influencing inappropriate surgical antibiotic prophylaxis prescribing in Kuwait : qualitative study
Alshatti F, Boyter A, Taqi A, Kurdi A
11th Nordic Social Pharmacy Conference (2025)
Investigating the contribution of socioeconomic position to ethnic inequalities in severe COVID-19 outcomes : population-based mediation analyses of national linked Scottish data
Amele Sarah, Kibuchi Eliud, McCabe Ronan, Demou E, Leyland Alastair H, Hainey Kirsten J, Rudan Igor, Kurdi Amanj, Simpson Colin R, Ritchie L D, McCowan Colin, Shi T, Irizar Patricia, Becares Laia, Sheikh A, Pearce A, Vittal Katikireddi Srinivasa
European Journal of Public Health (2025)
Status and implications of the knowledge, attitudes and practices towards AWaRe antibiotic use, resistance and stewardship among low- and middle-income countries
Saleem Zikria, Moore Catrin E, Kalungia Aubrey C, Schellack Natalie, Ogunleye Olayinka, Chigome Audrey, Chowdhury Kona, Kitutu Freddy Eric, Massele Amos, Ramdas Nishana, Orubu E Sam, Cook Aislinn, Khuluza Felix, Zaranyika Trust, Funiciello Elisa, Lorenzetti Giulia, Nantamu Miriam, Parajuli Ayuska, Kurdi Amanj, Nabayiga Hellen, Jairoun Ammar Abdulrahman, Haque Mainul, Campbell Stephen M, Van Der Bergh Dena, Godman Brian, Sharland Mike
JAC-Antimicrobial Resistance Vol 7 (2025)
https://doi.org/10.1093/jacamr/dlaf033
A population-based study of incident prescribing for hypercholesterolaemia and hypertension in Scotland : is the healthcare system recovering from the impact of COVID-19?
Kurdi Amanj, Millar Morven, Nnabuko Uchenna, McTaggart Stuart, Mueller Tanja, Proud Euan, Melia Barry, Bennie Marion
Current Medical Research and Opinion Vol 41 , pp. 447–453 (2025)
https://doi.org/10.1080/03007995.2025.2482674

More publications

Back to staff profile

Professional Activities

Invited Guest Speaker at the 15th International Congress of Pharmaceutical Sciences (CIFARP 2025)around Real-world evidence
Speaker
29/10/2025
External Examiner for the “Professional Certificate in Pharmacoepidemiology & Pharmacovigilance” course at London School of Hygiene and Tropical Medicine
Examiner
24/2/2025
Iraqi Journal of Pharmacy (Journal)
Peer reviewer
13/8/2024
Positioning Pharmacists in advancing Primary Health Care
Speaker
13/6/2024
Advances in Pharmacy and Pharmacoepidemiology Education in Kenya and Globally
Speaker
13/6/2024
Applied Pharmacoepidemology
Speaker
11/6/2024

More professional activities

Projects

Real world effectiveness of Tirzepatide, Semaglutide, and Liraglutide effects on Lipid Profile, Blood Pressure, body weight, HbA1c and heart rate among diabetic and non-diabetic patients: A Systematic Review and meta-analysis of Observational Studies
Alotaibi, Eman (Principal Investigator) Kurdi, Amanj (Principal Investigator) Alotaibi, Badriah (Academic)
01-Jan-2024 - 30-Jan-2025
Cancer Medicines Outcomes Programme - Public Health Scotland
Dunlop, Emma (Co-investigator) Mueller, Tanja (Co-investigator) Bennie, Marion (Principal Investigator) Kurdi, Amanj (Co-investigator) Lu, Liya (Researcher) Kavanagh, Kimberley (Co-investigator)
The aim of CMOP-PHS is to better understand the real world outcomes of cancer medicines for cancer patients in Scotland. The project is a collaboration between the University of Strathclyde, Public Health Scotland and the NHS Health Boards.
01-Jan-2024 - 31-Jan-2027
Prescribing medicines use in pregnancy: A scoping review protocol
Parvin, Mst Irin (Principal Investigator) Mueller, Tanja (Principal Investigator) Kurdi, Amanj (Principal Investigator)
Medication use during pregnancy can have detrimental effects on the mother as well as the unborn child, which might be unknown. Studies on medicine use during pregnancy can provide valuable information about the medications that pregnant women most frequently use for the diseases they are prescribed and whether or or not using these medications could be harmful for the mother and/or the unborn child. Findings from this scoping review will provide an insight of the medicines used during pregnancy as well as a comprehensive summary of the current evidence on this topic.
10-Jan-2024 - 14-Jan-2024
PHS Medicines Programme
Kurdi, Amanj (Principal Investigator) Mueller, Tanja (Co-investigator)
01-Jan-2023 - 30-Jan-2028
Profiling and assessing medicines use in pregnancy in Scotland: a population-based, whole system prescribing approach using routine data from clinical care
Mueller, Tanja (Principal Investigator) Kurdi, Amanj (Co-investigator)
01-Jan-2023 - 30-Jan-2027
22/145 Systems Engineering Innovation hubs for Multiple longterm Conditions - Development phase
Maier, Anja (Principal Investigator) Connolly, Patricia (Co-investigator) Gray, Louise (Co-investigator) Inns, Tom (Co-investigator) Kurdi, Amanj (Co-investigator) Maguire, Roma (Co-investigator) Mehnen, Jorn (Co-investigator) Michie, Craig (Co-investigator) Mueller, Tanja (Co-investigator) Picanco Rodrigues, Vinicius (Co-investigator) Tachtatzis, Christos (Co-investigator) Whitfield, Ian (Co-investigator)
01-Jan-2023 - 31-Jan-2025

More projects

Back to staff profile

Contact

Professor Amanj Kurdi
Strathclyde Institute of Pharmacy and Biomedical Sciences

Email: amanj.baker@strath.ac.uk
Tel: 548 2181